Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-02-06, Stock:JNJ, The news for the past five days is as follows:
2020-01-30: NEWS1: J&J (JNJ) Plans to Develop Vaccine for New Coronavirus.NEWS2: Coronavirus update: US records first human-to-human transmission as WHO declares global emergency.NEWS3: Hedge Fund Hotels in 2020: Visa Inc (V) vs. Market Cap Peers.NEWS4: Biogen (BIIB) Surpasses Q4 Earnings and Sales Estimates.NEWS5: Montco biopharm firm's stock surges again on new coronavirus pact.NEWS6: The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance.
2020-01-31: NEWS1: Johnson & Johnson Is Ordered to Pay California Over Deceptive-Marketing Claim.NEWS2: Some Drugmakers Are Racing to Develop a Coronavirus Vaccine. Why Big Pharma Isn’t Rushing In..NEWS3: Pharma Stock Roundup: LLY, PFE Q4 Results, JNJ's Coronavirus Vaccine Initiative.NEWS4: Bayer wins EU recommendation for prostate cancer drug.NEWS5: The Wining Sector & Its Top Stocks in Virus-Infected January.NEWS6: PRESS DIGEST-New York Times business news - Jan 31.
2020-02-03: NEWS1: Arrowhead (ARWR) to Report Q1 Earnings: What's in the Cards?.NEWS2: Vaxart (VXRT) to Make Vaccines to Check Coronavirus, Stock Up.NEWS3: Merck (MRK) to Report Q4 Earnings: Is a Beat in the Offing?.
2020-02-04: NEWS1: Coronavirus update: China toll skyrockets, but markets calm amid government cash infusion.NEWS2: AbbVie (ABBV) to Report Q4 Earnings: What's in the Cards?.NEWS3: FDA to hold public meeting on testing for asbestos in talc.
2020-02-05: NEWS1: FOCUS-Drugmakers see long road ahead in coronavirus vaccine race.NEWS2: WHO Says There's No Effective Coronavirus Treatment Yet.NEWS3: Regeneron Expands Agreement to Develop Coronavirus Therapy.NEWS4: Can Humira/Cancer Drugs Help AbbVie (ABBV) Beat Q4 Earnings?.NEWS5: Theravance Pipeline Strong, Dependence on Yupelri a Concern.NEWS6: Merck (MRK) Beats on Q4 Earnings, Plans Women Health Spin Off.NEWS7: Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?.

Answer: Decrease